Eyewire News

Featured Story

AAO, AOA Respond to FDA GLP-1 Drug Labeling Changes, Highlight NAION Risk and Eye Care Recommendations image

11.11.2026

AAO, AOA Respond to FDA GLP-1 Drug Labeling Changes, Highlight NAION Risk and Eye Care Recommendations

The American Academy of Ophthalmology (AAO), North American Neuro-Ophthalmology Society (NANOS), and American Optometric Association (AOA) have responded to the FDA's decision to require new safety warnings for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) regarding a potential increased risk of nonarteritic anterior ischemic optic neuropathy (NAION). The AAO stated that the FDA's new analyses are broadly consistent with its May 2026 joint statement with NANOS, which concluded that GLP-1 RA use may be associated with NAION.

Read Story

Latest News Stories

11.11.2026

American Academy of Optometry Identifies Gaps and Future Priorities in Low Vision Research

Cure Blindness Project Launches 2026 Holiday Gift Catalog to Support Global Eye Care image

11.11.2026

Cure Blindness Project Launches 2026 Holiday Gift Catalog to Support Global Eye Care

Mogrify to Present Preclinical Data on Retinal Regeneration Therapy at FLORetina-ICOOR 2026 image

11.11.2026

Mogrify to Present Preclinical Data on Retinal Regeneration Therapy at FLORetina-ICOOR 2026

Imvionix Acquires US and Canadian Commercial Rights to Beovu from Novartis image

11.10.2026

Imvionix Acquires US and Canadian Commercial Rights to Beovu from Novartis

Zeiss Receives Approval in China for PT Lunana Phakic IOL image

11.10.2026

Zeiss Receives Approval in China for PT Lunana Phakic IOL

11.10.2026

FDA Requires New Warning for NAION Risk Across All GLP-1 Receptor Agonists

11.10.2026

Epion Therapeutics Reports Association Between Keratoconus Severity and Endothelial Cell Density in Phase 3 Study

11.10.2026

City Therapeutics Doses First Participant in Phase 1 Trial of CITY-RBP4 for Stargardt Disease

11.09.2026

Viridian Therapeutics Reports Positive Phase 1 Results for VRDN-008, Plans Registrational Trial in 2027

Tenpoint Therapeutics Launches Telehealth Prescribing Program for Yuvezzi image

11.09.2026

Tenpoint Therapeutics Launches Telehealth Prescribing Program for Yuvezzi

Zeiss Launches YouTube and TikTok Video Series to Expand Consumer Eye Health Education image

11.09.2026

Zeiss Launches YouTube and TikTok Video Series to Expand Consumer Eye Health Education

11.09.2026

Ianalumab Reduces Disease Activity in Sjögren’s Disease in Two Phase 3 Trials

11.06.2026

Study Links Colder Temperatures to Higher IOP in Patients with Glaucoma

11.06.2026

SpaMedica Report Raises Concerns Over Mandatory Cataract Surgery Waiting Times in England

11.06.2026

Founders Optical Unveils Refreshed Brand Following Acquisition by Newton

CMS Establishes Practice Expense Supply Code for TearCare SmartLids image

11.06.2026

CMS Establishes Practice Expense Supply Code for TearCare SmartLids

VeonGen Therapeutics Secures FDA Alignment on Phase 3 Development of VG801 for Stargardt Disease image

11.06.2026

VeonGen Therapeutics Secures FDA Alignment on Phase 3 Development of VG801 for Stargardt Disease

11.06.2026

Studies Link Cataract Surgery to Improved Quality of Life and Economic Security in Rural Mozambique

Link Biologics Completes IND-Enabling Preclinical Program for Dry Eye Disease Therapy LB001 image

11.05.2026

Link Biologics Completes IND-Enabling Preclinical Program for Dry Eye Disease Therapy LB001

View More